The Intelligent Pills Market is projected to reach USD 7.70 Billion by 2032 at 8.6% CAGR during the forecast period 2032. The intelligent/smart pills systems works on the foundation of IEM Ingestible Event Markers that can either be integrated into pills or plow into pharmaceuticals as a feature of the assembling process.
In this method the sensor will be installed in a placebo to be taken along with medicine. Many leading pharmaceutical companies hope to make this framework which will be marketed to people with chronic conditions.
In November 2022, Eli Lilly and Company began the rollout of its first connected platform, known as the Tempo® Personalized Diabetes Management Platform. It is a technology that aims to assist adults suffering from type 1 diabetes or type 2 diabetes, as well as clinicians, in making treatment decisions supported by data from the company on using Lilly insulins. Smart Button®, an app called TempoSmart™, and Tempo Pen® are three interrelated components that make up the platform, offering individualized guidance to adult diabetics. On September 16th, the Smart Button was given clearance by the US Food and Drug Administration Clearances. The associated app has been developed with partners like Welldoc®; it is a private-labeled version of BlueStar®, a diabetes management app adapted to receive insulin dose-related data from Tempo Smart Button.
Amazon recently held its long-awaited Devices & Services event for 2023 in September, where it launched several high-tech smart home products that were anticipated by many people. These revolutionary gadgets will be available next month, just in time for shoppers during the holiday season. For product launch, Amazon has planned for the Amazon Early Access Sale next month and the Black Friday sale, which is highly awaited in November. In addition to an impressive array of new hardware, Amazon featured significant improvements to Alexa powered by generative AI. This translates into more natural and engaging conversations with your digital assistant.
Olo introduced Smart Cross-Sells, which will enhance guest engagement and increase average order value within restaurants in April 2024. The feature supports restaurant brands with dynamic, personalized recommendations throughout ordering and checkout. Other features include Order, Pay, and Engage under Olo’s suite of products aimed at increasing orders for restaurants as well as optimizing operations. Olo's Smart Cross-Sells leverage AI to suggest intelligent orders based on factors such as order history menu options at the guest's location, time of day, and items currently in the cart.
Intelligent/smart pill systems are built around the IEM Ingestible Event Markers, which can be mixed into pills or plowed into drugs during manufacturing. In this method, a placebo will be taken with the drug and contain the sensor. Several leading pharmaceutical companies are working to create this structure, which will be made available to those with chronic illnesses. Smart pills are ingestible, capsule-sized medical gadgets with cameras, sensors, patches, and trackers that aid in more accurate diagnosis, patient monitoring, and targeted drug delivery. They often come in the shape of pills the size of vitamin capsules and have a tiny wearable sensor patch, a smartphone app, and a provider site.
After being ingested, it activates in the stomach; the sensors then offer data on the patient's health conditions and the efficacy of drug treatment, enabling better-informed medical decisions and tailored treatments. Capsule endoscopy is one of several cutting-edge procedures that have emerged due to the high demand for less invasive surgical procedures. Capsule endoscopy is anticipated to displace conventional endoscopic techniques due to benefits including simplicity of administration and thorough viewing of the gastrointestinal tract. Moreover, smart tablets have completely transformed the discipline of gastrointestinal diagnosis. Being non-invasive, smart tablets can be an effective alternative to invasive procedures like gastrointestinal endoscopy and colonoscopy.
The rise in chronic diseases like cancer, diabetes, and others, as well as the rising prevalence of lifestyle-related illnesses like weight gain, gastroesophageal reflux disease (GERD), ulcers of the stomach, and others, are the main factors driving the growth of the smart pill market. Globally, a growing number of lifestyle-related disorders, including gastrointestinal reflux diseases, gastric ulcers, and others, as well as the increasing incidence of long-term illnesses like colorectal and breast cancer, are some of the key factors predicted to fuel the demand for advanced treatment options. During the projected period, the market for smart pills is anticipated to rise as patient preferences for minimally invasive treatments for treatment shift. Increased R&D expenditures for creating smart pills also expand the market. The expensive cost of the ingestible sensors and strict government rules regarding the expanding use of these devices are the two reasons that are expected to slow the market's expansion.
Three well-known smart medications, modafinil, dextroamphetamine, and methylphenidate, were the subject of a new study released in Science Advances that looked at how they affected real-world tasks. The theory put up by the researchers was that these medications, which affect norepinephrine and dopamine, would impact effort and motivation, ultimately improving performance.
Intelligent Pills market has been segmented on the basis of applications which consist of boost in sleeping disorders, capsule endoscopy, Reflux Monitoring, Mobility Monitoring, Stress Management and others.
By prescription type which includes prescription smart drugs and others.
A new, non-invasive system has been created by a research team under the direction of Khalil Ramadi, an assistant professor of Bioengineering at NYU Abu Dhabi (NYUAD). This technology will make it easier to diagnose and treat gastrointestinal motility disorders. The researchers have created 3D magnetic field gradients utilizing high-frequency electromagnetic coils that imprint each spatial point with a unique magnetic field magnitude to follow the travel of an ingestible "smart pill" through the GI tract. The "smart pill" measures and transmits the field magnitude to pinpoint its exact location and is then relayed via Bluetooth to a smartphone.
Americas
Europe
Asia– Pacific
The Middle East& Africa
The report for Intelligent Pills market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 7.70 Billion |
| Â Â CAGR | Â Â 8.6% |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | By Applications, By Prescription |
| Â Â Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | CapsoVision, Inc. (US), Given Imaging Ltd. (Israle), Medimetrics (Mexico), (Bio-Images Drug Delivery) BDD LTD (UK), Proteus Digital Health (US), among others |
| Â Â Key Market Opportunities | New product launches and R&D Amongst major key Players |
|   Key Market Drivers | · Favorable reimbursement scenario · Patient preference for minimally invasive procedures · Technological advancements in endoscopy procedures · Rising prevalence of colon cancer |
Intelligent Pills Market Highlights:
Frequently Asked Questions (FAQ) :
The Intelligent Pills Market is projected to reach USD 7.70 billion by 2032, growing at a CAGR of 8.6%.
Intelligent Pills are based on Ingestible Event Markers (IEM), which are integrated into pills or pharmaceutical processes.
Key players include CapsoVision, Given Imaging, Medimetrics, BDD Ltd., and Proteus Digital Health.
Applications include sleeping disorders, capsule endoscopy, reflux monitoring, mobility monitoring, stress management, and others.
The market is divided into prescription smart drugs and non-prescription smart pills.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
